Cite
MLA Citation
K. Papadopoulos et al.. “Early evidence of dose-dependent pharmacodynamic activity following treatment with SY-5609, a highly selective and potent oral CDK7 inhibitor, in patients with advanced solid tumors.” European journal of cancer, vol. 138, n.d., pp. S50–. http://access.bl.uk/ark:/81055/vdc_100120043988.0x000027